Synthesis and antifungal evaluation of new azole derivatives containing 1,2,3-triazole
RSC Medicinal Chemistry · 2025 · 16 (2) · 791-800
DOI: 10.1039/d4md00724g ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Medicinal Chemistry, 2025. Verfasst von Zhengxiao Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Yunnan University of Chinese Medicine Kunming 650500 PR China wangrryucm@126.com hchuny@126.com maozw@ynucm.edu.cn. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Yunnan Key Research and Development Program, Yunnan Provincial Science and Technology Department.
Abstract (Originalsprache)
A series of novel azole derivatives containing 1,2,3-triazole have been synthesized with good antifungal effects on sensitive and drug-resistant C. albicans .
Autor:innen und Institutionen
- School of Chinese Materia Medica, Yunnan University of Chinese Medicine Kunming 650500 PR China wangrryucm@126.com hchuny@126.com maozw@ynucm.edu.cn.
ORCID-Profile: Chunyan Hu, Zewei Mao
Förderung
- Yunnan Key Research and Development Program
- Yunnan Provincial Science and Technology Department
Zitieren
APA
Huang, Z., Chen, H., Zhang, X., Wang, R., Hu, C., & Mao, Z. (2025). Synthesis and antifungal evaluation of new azole derivatives containing 1,2,3-triazole. RSC Medicinal Chemistry, 16(2), 791-800. https://doi.org/10.1039/d4md00724g
Vancouver
Huang Z, Chen H, Zhang X, Wang R, Hu C, Mao Z. Synthesis and antifungal evaluation of new azole derivatives containing 1,2,3-triazole. RSC Medicinal Chemistry. 2025;16(2):791-800. doi:10.1039/d4md00724g
BibTeX
@article{Huang2025,
author = {Huang, Zhengxiao and Chen, Hongjie and Zhang, Xiao and Wang, Ruirui and Hu, Chunyan and Mao, Zewei},
title = {Synthesis and antifungal evaluation of new azole derivatives containing 1,2,3-triazole},
journal = {RSC Medicinal Chemistry},
year = {2025},
volume = {16},
number = {2},
pages = {791--800},
doi = {10.1039/d4md00724g}
}
EUVIMED